CXCL9 and cancer: Previous reports suggested that anti-cancer drugs such as cisplatin and hydroxyurea induced mRNA expression of CXCL9/10/11 through cell cycle-specific DNA damage in human cancer cells26,27, and the DNA topoisomerase I inhibitor, irinotecan, is also known to cause cell cycle-specific DNA damage16,30.